1253. Antimicrobial Activity of Cefepime in Combination with Taniborbactam Against Clinical Isolates of Enterobacterales from 2018-2020 Global Surveillance

BACKGROUND: Taniborbactam (formerly VNRX-5133) is a novel cyclic boronate-based broad-spectrum β-lactamase inhibitor with potent and selective direct inhibitory activity against both serine- and metallo-β-lactamases (Ambler Classes A, B, C and D). Taniborbactam restores the activity of cefepime agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Hackel, Meredith, Wise, Mark G G, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644281/
http://dx.doi.org/10.1093/ofid/ofab466.1445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644281/
http://dx.doi.org/10.1093/ofid/ofab466.1445

Ejemplares similares